Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-553-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Ames test:
The mutagenic activity of the substance in the bacterial reverse mutation test was evaluated in accordance with OECD guideline 471 and GLP. The test was performed in two independent experiments using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100 and the Escherichia coli strain WP2uvrA, in the absence and presence of a liver fraction of Aroclor 1254-induced rats. The dose levels were selected based on observed cytotoxicity. Adequate negative and positive controls were included. In both tests, in all strains tested, in both the absence and presence of S9-mix, the test substance did not induce a more than 2-fold and/or dose related increase in the mean number of revertant colonies compared to the background spontaneous reversion rate observed with the negative control. It is concluded that the results obtained in Salmonella typhimurium strains TA 1535, TA 1537, TA 98 and TA 100, and in the Escherichia coli strain WP2 uvrA, in both the absence and presence of the S9-mix, indicate that the test substance is not mutagenic under the conditions employed in this study.
Chromosome aberration test:
The cytogenicity of the test substance was determined in an in vitro mammalian cell chromosome aberration test, performed according to OECD 473 and in compliance with GLP. The test was performed in human lymphocytes in both the absence and presence of a metabolic activation system (S9 -mix). The test substance was dissolved in DMSO and the dose levels were selected based on observed cytotoxicity. Adequate negative and positive controls were included. In the first chromosomal aberration test, in both the absence and presence of S9-mix, the treatment/harvesting times were 4/24 hours (pulse treatment). Cells were treated with 2 - 1000 µg/mL test substance. In the absence and presence of S9-mix, no test substance concentration could be selected that fulfilled the criteria stated in OECD guideline 476 (i.e. a maximum concentration which resulted in 55 ± 5% cytotoxicity). Therefore, the pulse treatment groups, both with and without metabolic activation, were repeated in the second test. In the second test, in the pulse treatment groups both with and without metabolic activation, the treatment/harvesting times were 4/24 hours. In the continuous treatment group without metabolic activation the treatment/harvesting times were 24/24 hours. In the pulse treatment groups in absence of S9 -mix cells were exposed to 50 - 250 µg/mL test substance and in the presence of S9 -mix cells were exposed to 50 - 350 µg/mL test substance. In the continuous group, cells were exposed to 25 - 300 µg/mL test substance. In this chromosomal aberration test, the test substance did not induce a statistically significant increase in the number of aberrant cells, at any of the concentrations and treatment periods analysed, when compared to the number of aberrant cells observed in the solvent control cultures. From the results obtained in two chromosomal aberration tests it is concluded that, the test substance was not clastogenic to cultured human lymphocytes, under the conditions used in this study.
Short description of key information:
Ames test (OECD TG 471): negative
Chromosome aberration test (OECD TG 473): negative
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the results of the Ames test and the chromosome aberration test, the test substance does not have to be classified for mutagenicity in accordance with Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.